Indian patent act 2005 in perspective of biotechnological researches, health and industry

It has been a challenge to understand the patentability matters in health care area in particular Biopharmaceuticals in India. Major biopharmaceutical companies have increased their investment in research and development from several million US dollars to several billion dollars in past decades. Now, these days big biopharma companies are focusing on extensive analysis of patentability and placing of strategies on patent portfolio management as it showed a pay off strategy in long run in health care area. Recently, Government's focus to address the needs of human health on emerging diseases, formulation of legislations, availability of off-patented biosimilars, tax-free incentives made this sector as a top priority sector for investment for many of global investors. Thus, outcomes from the research and development departments in way of patents are critical for the health of biopharmaceuticals. Globally big Indian Biopharmaceutical companies are also keeping eyes to patent their biological inventions to increase their longevity and monopoly in the market. Unfortunately, there are no clear criteria's for patentable matters in biotechnological inventions under Indian patent act 2005.